Skip to main content

and
  1. Article

    Open Access

    Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes

    We investigated the survival of female patients with pre-existing type 2 diabetes (T2D) diagnosed with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) of breast, in relation to the use of ...

    Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila in Scientific Reports (2021)

  2. Article

    Open Access

    Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes

    To address the possible association between the use of metformin, other forms of antidiabetic medication (ADM) and statins with the incidence of breast cancer in women with type 2 diabetes (T2D).

    Mayu Hosio, Elina Urpilainen, Mikko Marttila in Breast Cancer Research and Treatment (2019)

  3. Article

    Open Access

    Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study

    Ovarian cancer is one of the most lethal cancers and women with type 2 diabetes (T2D) have even poorer survival from it. We assessed the prognosis of ovarian cancer in women with type 2 diabetes treated with m...

    Elina Urpilainen, Mikko Marttila, Ari Hautakoski, Martti Arffman, Reijo Sund in BMC Cancer (2018)